{
  "pmid": "31553845",
  "uid": "31553845",
  "title": "Clinical and Genomic Risk in Adjuvant Therapy for Breast Cancer.",
  "abstract": "",
  "authors": [
    {
      "last_name": "Giorgi Rossi",
      "fore_name": "Paolo",
      "initials": "P",
      "name": "Paolo Giorgi Rossi",
      "affiliations": [
        "Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy paolo.giorgirossi@ausl.re.it."
      ]
    },
    {
      "last_name": "Lebeau",
      "fore_name": "Annette",
      "initials": "A",
      "name": "Annette Lebeau",
      "affiliations": [
        "University Medical Center Hamburg-Eppendorf, Hamburg, Germany."
      ]
    },
    {
      "last_name": "Schünemann",
      "fore_name": "Holger J",
      "initials": "HJ",
      "name": "Holger J Schünemann",
      "affiliations": [
        "McMaster University, Hamilton, ON, Canada."
      ]
    },
    {
      "affiliations": []
    }
  ],
  "journal": {
    "title": "The New England journal of medicine",
    "iso_abbreviation": "N Engl J Med",
    "issn": "1533-4406",
    "issn_type": "Electronic",
    "volume": "381",
    "issue": "13",
    "pub_year": "2019",
    "pub_month": "Sep",
    "pub_day": "26"
  },
  "start_page": "1289",
  "end_page": "1290",
  "pages": "1289-1290",
  "language": "eng",
  "publication_types": [
    "Letter",
    "Comment"
  ],
  "keywords": [
    "Breast Neoplasms",
    "Chemotherapy, Adjuvant",
    "Combined Modality Therapy",
    "Genomics",
    "Humans"
  ],
  "article_ids": {
    "pubmed": "31553845",
    "doi": "10.1056/NEJMc1909693",
    "pii": "10.1056/NEJMc1909693#sa2"
  },
  "doi": "10.1056/NEJMc1909693",
  "dates": {
    "completed": "2019-09-27",
    "revised": "2024-01-05"
  },
  "chemicals": [],
  "grants": [],
  "search_metadata": {
    "search_type": "current_affiliation",
    "retrieved_date": "2025-07-30T14:56:42.676920",
    "pmid": "31553845"
  }
}